Online program to help prevent sexual assault in college women
A Randomized Controlled Trial of the Efficacy of IDEA3 - An Evidence-based Sexual Assault Resistance Intervention for Undergraduate Women Adapted for Internet Delivery
This study tests whether an online program that teaches college women how to resist sexual assault is more effective at preventing victimization than a shorter workshop on consent.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1920 (estimated) |
| Ages | 17 Years to 24 Years |
| Sex | All |
| Sponsor | University of Maryland, College Park Academic / other |
| Locations | 6 sites (Orlando, Florida and 5 other locations) |
| Trial ID | NCT06058455 on ClinicalTrials.gov |
What this trial studies
This randomized trial evaluates the effectiveness of the Internet-Delivered Enhanced Assess, Acknowledge, Act (IDEA3) program in reducing sexual violence victimization among undergraduate women. Participants in the intervention group will attend four three-hour sessions focused on sexual assault resistance, while the control group will attend a one-hour consent workshop. The study aims to compare rates of sexual assault victimization between the two groups over a one-year follow-up period. The program is designed to equip young women with skills and knowledge to assess and respond to potentially dangerous situations.
Who should consider this trial
Good fit: Ideal candidates are female-identifying first- and second-year university students aged 17-24 who can attend scheduled program groups.
Not a fit: Patients who do not identify as female or are not enrolled in university during the study period may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly reduce the incidence of sexual violence among college women.
How similar studies have performed: Previous studies have shown that similar sexual assault resistance programs can significantly reduce victimization rates, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1st- and 2nd-year university students at one of the 4 sites * female-identifying students * students between ages of 17-24 * able to attend one of the scheduled program groups * able and willing to be matched with another eligible student Exclusion Criteria: \- None
Where this trial is running
Orlando, Florida and 5 other locations
- University of Central Florida — Orlando, Florida, United States (Recruiting)
- University of Maryland — College Park, Maryland, United States (Recruiting)
- University of Michigan — Ann Arbor, Michigan, United States (Recruiting)
- University of Nebraska - Lincoln — Lincoln, Nebraska, United States (Completed)
- University of Guelph — Guelph, Ontario, Canada (Recruiting)
- University of Windsor — Windsor, Ontario, Canada (Active_not_recruiting)
Study contacts
- Principal investigator: Sarah M Peitzmeier, PhD — University of Maryland
- Study coordinator: Sarah M Peitzmeier, PhD
- Email: speitzme@umd.edu
- Phone: 301 405 2526
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.